Investor Ideas #Potcasts; #Cannabis News
and Stocks on the Move; TSX: $ACB.TO,
TSXV: $ICC.V, CSE: $LILY.C, TSX: $HEXO.TO
Global
medical cannabis market was valued US$ 3.52 Billion in 2017
Pt. Roberts, WA; Delta, BC –June 26, 2018
(Investorideas.com Newswire) www.Investorideas.com, a global news source
covering leading sectors including marijuana and hemp stocks and its “potcast’
site, www.potcasts.ca release today’s edition of its series, Investorideas.com potcastsCM -
cannabis news and stocks to watch plus insight from thought leaders and experts.
Read this in full at http://www.investorideas.com/news/2018/cannabis/06265Potcasts-TSXACBICCHEXOCSELILY.asp
Today’s podcast overview/transcript:
Good afternoon and welcome to another Investorideas.com potcast ;
looking at cannabis news, stocks to watch as well as insights from thought
leaders and experts. Today’s podcast features
news announcements from Aurora
Cannabis Inc. trading (TSX: ACB and
OTCQB:ACBFF) , ICC Labs Inc ( TSX-Venture: ICC) , Callitas ( CSE:
LILY and OTCQB:
MPHMF) and The Hydropothecary
Corporation ( TSX:
HEXO).
But first,
according to Coherent Market Insights the global medical cannabis market was
valued US$ 3.52 Billion in 2017 and is projected to exhibit a compound annual
growth rate of 24.4% over the forecast period of 2017 – 2025.
The
Cannabidiol (CBD) segment is expected to gain significant traction over the
forecast period, on account of the continuous engagement of manufacturers to
introduce Hemp Cannabidiol products in various forms
Among
therapeutic application, pain segment accounted for the largest market share,
owing to increase in government initiatives to enable patients to use medicinal
marijuana, as a treatment in chronic pain management
Some of the
major players operating in the global medical cannabis market include BOL
Pharma, Tilray, Medreleaf Corporation, Aurora Cannabis, Inc., Canopy Growth
Corporation, Insys Therapeutics, Inc., Aphria, Inc., MGC Pharmaceuticals
Limited, GW Pharmaceuticals, plc, and Medical Marijuana Inc.
Aurora
Cannabis Inc. announced today that it has agreed to a new $200 million debt
facility, with a potential upsize to $250 million, with the Bank of Montreal
("BMO").
The facility
will consist of a $150 million term loan and a $50 million revolving credit
facility, both of which will mature in 2021. A short period after the
implementation of Bill C-45 in October 2018, the Company may request an
increase of up to a further $45 million to the term loan subject to agreement
by BMO and satisfaction of certain legal and business conditions. BMO will also
be providing up to $5 million in other credit instruments. Closing of the debt
facility is subject to completion of final due diligence, negotiation of
definitive documentation, and satisfaction of conditions precedent customary to
a financing of this nature.
The debt
facility will be primarily secured by Aurora's production facilities, including
Aurora Sky, Aurora Mountain, and Aurora Vie. Strategically located at Edmonton
International Airport, Aurora Sky is the world's most technologically advanced
cannabis facility, projected to produce in excess of 100,000 kg per year of
high-quality cannabis at low per gram costs, and slated to deliver its first
harvest this week.
ICC Labs
Inc. announced that the Government of Uruguay through its regulatory authority
IRCCA (Cannabis Regulation and Control Institute) has granted the Company an
additional land package of approximately 55,000 square foot in order to
increase its production capacity.
“A relevant
milestone that demonstrates the confidence that the Government has placed in
our Company to continue executing the terms of our recreational cannabis
license granted for 5 years on January 14, 2016,” commented Alejandro Antalich,
Chief Executive Officer of ICC Labs.
Callitas, an
integrated clinical-stage pharmaceutical development and OTC consumer goods
marketing company, announced today that it has entered into a non-exclusive
licensing and technology agreement with LifeStyles, LTD, the global leader in
the sexual wellness sector, for its non-branded, patented arousal gel and
lubricants for use on condoms and as a stand-alone product for retail and
consumer markets around the world.
“Partnering
of Callitas’ non-branded products and technologies to reach new markets and
sales channels is a critical component of our business model,” said James M.
Thompson, President and CEO. “Partnering with the worldwide leader in sexual
wellness, Lifestyles, LTD., is an outstanding way to expand our sales as we
look forward to a long-term, mutually beneficial future.”
Under the
terms of the agreement, Callitas will receive a variable, single-digit royalty
on net sales of all products sold worldwide by Lifestyles, LTD., on any of
their brands. Callitas will also assist LifeStyles, LTD., in the development of
additional sexual health and wellness retail consumer goods.
Finally, the
Hydropothecary Corporation, HEXO, announced that four zones of its 250,000 sq.
ft. greenhouse expansion are now licensed by Health Canada.
The
licensing of two additional zones aligns with HEXO’s continual harvest
methodology, which splits the greenhouse into zones that can be tailored to
each stage of plant growth.
“Four of ten
zones now have plants in and are fully operational, the other zones will follow
in the coming weeks, with all 10 zones set to be operational by August,” said
HEXO CEO and co-founder, Sébastien St-Louis.
“We are
confident we will be ready to fulfill our contract as the preferred supplier to
the Société québécoise du cannabis (SQDC) and are excited to see what the
future holds. These ongoing expansions, along with our innovative, high-quality
products, put us in an optimal position as we continue discussions with other
provincial authorities,” added Mr. St-Louis.
Investor ideas reminds
all listeners to read our disclaimers and disclosures on the
Investorideas.com website and this podcast is not an endorsement to buy
products or services or securities. Investors are reminded all investment
involves risk and possible loss of investment
Subscribe to the new cannabis podcast series:
Investorideas.com podcasts are also available on
iTunes, Google Play Music, Stitcher and Tunein.
Potcasts is now a certified word
mark Trademark on the blockchain through Cognate, Inc. CM
Certification-Registration Number: 10468217708
About Investorideas.com - News that Inspires
Big Ideas
Investorideas.com is
a meeting place for global investors, featuring news, stock directories, video,
company profiles, interviews and more in leading sectors.
Investorideas.com
cannabis/marijuana and hemp content now includes http://cannabisstocknews.blogspot.com on Blogger.com: the
Investorideas.com news and stock directory pages, a cannabis investor group on
Linkedin.com , the 420 Cannabis Investor ideas www.420cannabisinvestorideas.com, and the new AI site Global Cannabis Investing at www.Globalcannabisinvesting.com
Disclaimer/Disclosure: Investorideas.com is
a digital publisher of third party sourced news, articles and equity research
as well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases or
sale of stocks, services or products. Nothing on our sites should be construed
as an offer or solicitation to buy or sell products or securities. All
investment involves risk and possible loss of investment. This site is
currently compensated for news publication and distribution, social media and
marketing, content creation and more. Contact each company directly regarding
content and press release questions. Disclosure is posted for each compensated
news release, content published /created if required but otherwise the news was
not compensated for and was published for the sole interest of our readers and
followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp.
Additional info
regarding BC Residents and global Investors: Effective September 15 2008 - all
BC investors should review all OTC and Pink sheet listed companies for
adherence in new disclosure filings and filing appropriate documents with
Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations
of each country.
Follow us on Social Media
Contact Investorideas.com
800-665-0411
